Immunotherapy of cancer in the era of checkpoint inhibitor

被引：0
|
作者：
Inderjit Mehmi
Omid Hamid
机构：
[1] The Angeles Clinic and Research Institute,
[2] Cedar Sinai Affiliate,undefined
来源：
Clinical & Experimental Metastasis | 2022年 / 39卷
关键词：
Melanoma; cSCC; MCC; Immunotherapy; Checkpoint inhibitors; TIM-3; LAG-3; Cytokines; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Application of immunotherapy has revolutionized treatment of number of malignancies. We present a review of immunotherapy approaches, early-phase data of number of new immunotherapeutic targets in melanoma, cutaneous squamous cell carcinoma, Merkel cell cancer, and non-small cell lung cancer.
引用
收藏
页码：231 / 237
页数：6
相关论文
共 50 条
  • [1] Immunotherapy of cancer in the era of checkpoint inhibitor
    Mehmi, Inderjit
    Hamid, Omid
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (01) : 231 - 237
  • [2] Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
    Zekeridou, Anastasia
    Lennon, Vanda A.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (09) : 1865 - 1878
  • [3] Checkpoint inhibitor immunotherapy in kidney cancer
    Xu, Wenxin
    Atkins, Michael B.
    McDermott, David F.
    [J]. NATURE REVIEWS UROLOGY, 2020, 17 (03) : 137 - 150
  • [4] Checkpoint inhibitor immunotherapy in kidney cancer
    Wenxin Xu
    Michael B. Atkins
    David F. McDermott
    [J]. Nature Reviews Urology, 2020, 17 : 137 - 150
  • [5] Neurological complications of immune checkpoint inhibitor cancer immunotherapy
    Zivelonghi, Cecilia
    Zekeridou, Anastasia
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 424
  • [6] Autoimmune Polyarthritis Induced by Cancer Immunotherapy With Checkpoint Inhibitor
    Quresh, Quretul
    Quinet, Robert
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (04) : 235 - 235
  • [7] Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
    Nakajima, Hiromichi
    Nakatsura, Tetsuya
    [J]. IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 10 - 15
  • [8] Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy
    Zen, Yoh
    Yeh, Matthew M.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2019, 36 (06) : 434 - 440
  • [9] Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy
    Goleva, Elena
    Lyubchenko, Taras
    Kraehenbuehl, Lukas
    Lacouture, Mario E.
    Leung, Donald Y. M.
    Kern, Jeffrey A.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 630 - 638
  • [10] Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
    Xiong, Wei
    Zhao, Yunfeng
    Du, He
    Guo, Xuejun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
12345